TABLE 2.

Synthetic peptides prepared in this study

P3arv, reversed P3a peptide; P3am, mutated P3a peptide.

Blades B3B4-derived peptides
P1 (621–640)a	RGKMLLFSGRRLWRFDVKAQ
P2 (638–657)	KAQMVDPRSASEVDRMFPGV
P3 (654–674)	PGVPLDTHDVFQYREKAYFC
P4 (672–691)	YFCQDRFYWRVSSRSELNQV
P5 (689–707)	NQVDQVGYVTYDILQCPED
P3-derived peptides
P3a	FPGVPLDTHDVFQYREKb
P3b	VPLDTHDVFQb
P3arv	KERYQFVDHTDLPVGPF
P3am	FPGVPLATHAVFQYREKb
CS1, CS3 peptides
CS1	LVTLPHPNLHGPEILDVPST
CS3	TSGQQPSVGQQMIFEEHGFR
5(6)-Carboxyfluorescein-labeled peptides
CF-P3a	CF-FPGVPLDTHDVFQYREK
CF-P3am	CF-FPGVPLATHAVFQYREK
CF-CS1	CF-LVTLPHPNLHGPEILDVPST
CF-CS3	CF-TSGQQPSVGQQMIFEEHGFR

^a Numbers in parenthesis indicate the position within proMMP-9 of the amino acid residues contained in each peptide.

^b The two aspartate residues (D) mutated to alanine (A) are highlighted in bold.